Yup - but they have real traction and real management who know what they are doing - not a bunch of PEB clowns flying all over the US offering free tests while delivering nothing but promises to shareholders.
Printable View
https://www.nzx.com/announcements/333560
Bringing an ex-investment banker to the board - John Duncan, ex PGC.
http://www.stuff.co.nz/business/6809...uits-PGC-board
https://www.nzherald.co.nz/business/...ectid=11161419
No guesses needed as to why PEB has appointed him as a director!
https://www.insidermedia.com/insider...orth-east-fund
Guess DD will have a new job to go to when PEB finally bellies up - his ability to spin and raise funding from sucker institutions is now legendary!
https://stockhead.com.au/health/dr-b...field-of-play/
Sienna making much headways either, it seems.
But different strategy and they have not spent 10% of what PEB has burnt so far, to obtain same results.
Meanwhile, PEB sp heading back towards oblivion.
20c soon for sure!
https://medicalxpress.com/news/2019-...-outcomes.html
And so the research into how to best use urine tests to detect bladder cancer continues - putting a lie to PEB's claim it has the 'gold' standard.
Share price sliding faster and faster now towards 20c, first stop.
Seems like more shareholders are waking up to the gross exaggerations and failed promises of the directors and management, who continue to get paid huge salaries & benefits for non-delivery of results!
Selling pressure piling up and one gets the feeling that the sucker instos who have been underwriting are running out of patience to keep supporting the share price for the next capital raising.
So when is the next capital raising?
Well, 30 Sept 2018, PEB had $10.6m - really $8.7m because working capital was negative $1.9m.
A desperately arranged $7m capital raise via placement was made in Dec 2018 at 35c, and another $5m via the SPP in Jan 2019.
So we are now in May 2019 - 7 months on and we know PEB's cash burn is $1.5m a month which means the clock is ticking very loudly indeed for the next capital raise when the final results are announced later this month.
Share price fall suggests that PEB is already doing the rounds of asking the sucker instos for support?
And if PEB does not deliver on this : https://www.nzx.com/announcements/325254 by the time it reports its results in May, I think it is likely that even the most ardent & committed of the sucker instos will bail out too.
"The rate, set by the Medicare Advisory Panel on Clinical Diagnostic Laboratory Tests, will be open for public comment until 22 October 2018 and will be published in the Clinical Laboratory Fee Schedule in November 2018 and effective from 1 January 2019."
That announcement was of course made in October 2018 - just in time to get the instos to pump in more $$$ in Dec 2018 - but it's now 6 months with no update. With PEB, we know what that usually means! :eek2:
They havent achieved this yet have they? " and the third is inclusion in the Local Coverage Determination (LCD) for CMS coverage."